Correction: Genome Med 14, 67 (2022)
https://doi.org/10.1186/s13073-022-01071-5
The original publication of this article [1] contained an incorrect funding acknowledgement. The incorrect and correct information is listed in this correction article. The original article has been updated.
Incorrect
Camille and Henry Dreyfus Foundation and R35 GM13779501 from the National Institutes of Health (NIH) USA to S. Chandrasekaran
Correct
Camille and Henry Dreyfus Foundation and startup funds from the University of Michigan to S. Chandrasekaran.
Reference
Assante G, et al. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med. 2022;14:67. https://doi.org/10.1186/s13073-022-01071-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Assante, G., Chandrasekaran, S., Ng, S. et al. Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med 15, 38 (2023). https://doi.org/10.1186/s13073-023-01190-7
Published:
DOI: https://doi.org/10.1186/s13073-023-01190-7